Gene · 4919
Papers2,258
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,258
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Precision Immunotherapy Utilizing Adapter CAR-T Cells (AdCAR-T) in Metastatic Breast Cancer Leads to Target Specific Lysis. | Cancers (Basel) | 2023 | 38201595 | PubTator, text mining | PubMed |
| Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential. | Cancers (Basel) | 2023 | 38201551 | PubTator, text mining | PubMed |
| Current status and future challenges of CAR-T cell therapy for osteosarcoma. | Front Immunol | 2023 | 38187386 | PubTator, text mining | PubMed |
| Microbial metabolites are involved in tumorigenesis and development by regulating immune responses. | Front Immunol | 2023 | 38169949 | PubTator, text mining | PubMed |
| Epigenetic regulation and therapeutic strategies in ulcerative colitis. | Front Genet | 2023 | 38169708 | PubTator, text mining | PubMed |
| Brief Report: circRUNX1 as Potential Biomarker for Cancer Recurrence in EGFR Mutation-Positive Surgically Resected NSCLC. | JTO Clin Res Rep | 2023 | 38162176 | PubTator, text mining | PubMed |
| Generation and Characterization of SORT1-Targeted Antibody-Drug Conjugate for the Treatment of SORT1-Positive Breast Tumor. | Int J Mol Sci | 2023 | 38139459 | PubTator, text mining | PubMed |
| Frontiers of Molecular Biology of Cancer. | Int J Mol Sci | 2023 | 38139014 | PubTator, text mining | PubMed |
| Defining the Role of Metastasis-Initiating Cells in Promoting Carcinogenesis in Ovarian Cancer. | Biology (Basel) | 2023 | 38132318 | PubTator, text mining | PubMed |
| Microphysiological systems for solid tumor immunotherapy: opportunities and challenges. | Microsyst Nanoeng | 2023 | 38106674 | PubTator, text mining | PubMed |
| Advances and Challenges in Cancer Stem Cells for Onco-Therapeutics. | Stem Cells Int | 2023 | 38094260 | PubTator, text mining | PubMed |
| DIALing-up the preclinical characterization of gene-modified adoptive cellular immunotherapies. | Front Immunol | 2023 | 38090585 | PubTator, text mining | PubMed |
| Broadening the horizon: potential applications of CAR-T cells beyond current indications. | Front Immunol | 2023 | 38090582 | PubTator, text mining | PubMed |
| Fine-tuning the antigen sensitivity of CAR T cells: emerging strategies and current challenges. | Front Immunol | 2023 | 38090558 | PubTator, text mining | PubMed |
| Response to therapy in Richter syndrome: a systematic review with meta-analysis of early clinical trials. | Front Immunol | 2023 | 38077330 | PubTator, text mining | PubMed |
| Receptor tyrosine kinases: biological functions and anticancer targeted therapy. | MedComm (2020) | 2023 | 38077251 | PubTator, text mining | PubMed |
| Developing New Strategies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma. | J Clin Med | 2023 | 38068428 | PubTator, text mining | PubMed |
| New Insights into YAP/TAZ-TEAD-Mediated Gene Regulation and Biological Processes in Cancer. | Cancers (Basel) | 2023 | 38067201 | PubTator, text mining | PubMed |
| Characterization of novel CD19-specific VHHs isolated from a camelid immune library by phage display. | J Transl Med | 2023 | 38066569 | PubTator, text mining | PubMed |
| CAR-T cell therapy for hematological malignancies: History, status and promise. | Heliyon | 2023 | 38027932 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4919/papers?page=12